ranimustine and busulfan
ranimustine has been researched along with busulfan in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Masaoka, T | 1 |
| Hiraoka, A; Horiuchi, A; Kawagoe, H; Kitani, T; Masaoka, T; Miyazaki, T; Nakamura, T; Shibata, H; Yasunaga, K; Yonezawa, T | 1 |
| Fujitake, H; Hirota, Y; Kimura, K; Kitani, T; Masaoka, T; Miyazaki, T; Nakamura, T; Ohkubo, H; Okamoto, Y; Yasunaga, K | 1 |
| Ashihara, E; Fujita, N; Goto, H; Hirata, T; Inaba, T; Nakagawa, M; Okawa, K; Oku, N; Shimazaki, C; Yamagata, N | 1 |
| Hirose, Y; Masaki, Y; Sugai, S | 1 |
| Iwasaki, H; Kurosawa, M | 1 |
| Kubota, Y; Waki, M | 1 |
Trials
3 trial(s) available for ranimustine and busulfan
| Article | Year |
|---|---|
[Ranimustine].
Topics: Antineoplastic Agents; Busulfan; Drug Evaluation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Nitrosourea Compounds; Polycythemia Vera; Randomized Controlled Trials as Topic; Remission Induction | 1990 |
A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
Topics: Adult; Aged; Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Random Allocation; Remission Induction | 1988 |
[Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
Topics: Adult; Aged; Antineoplastic Agents; Busulfan; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Random Allocation | 1985 |
Other Studies
4 other study(ies) available for ranimustine and busulfan
| Article | Year |
|---|---|
Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
Topics: Acute Disease; Adolescent; Adult; Blood Component Transfusion; Busulfan; Combined Modality Therapy; Etoposide; Female; Flow Cytometry; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Leukemia, Myeloid; Leukocyte Count; Leukopenia; Lymphocyte Subsets; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Busulfan; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 8; Disease Progression; Female; Humans; Hydroxyurea; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Nitrosourea Compounds; Thrombocythemia, Essential; Trisomy | 2002 |
Megakaryoblastic transformation of polycythemia vera with hypercalcemia.
Topics: Adrenocorticotropic Hormone; Bone Resorption; Busulfan; Calcium; Cell Transformation, Neoplastic; Diphosphonates; Fatal Outcome; Humans; Hypercalcemia; Leukemia, Megakaryoblastic, Acute; Male; Middle Aged; Nitrosourea Compounds; Pamidronate; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Peptide Fragments; Polycythemia Vera; Proteins | 2002 |
[Long-term remission of non-Hodgkin lymphoma secondary to the treatment for essential thrombocythemia].
Topics: Alkylating Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Nitrosourea Compounds; Primary Myelofibrosis; Remission Induction; Rituximab; Thrombocythemia, Essential; Time Factors | 2009 |